We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,116 results
  1. Functional interplay between long non-coding RNAs and Breast CSCs

    Breast cancer (BC) represents aggressive cancer affecting most women’s lives globally. Metastasis and recurrence are the two most common factors in a...

    Bashdar Mahmud Hussen, Ramiar Kamal Kheder, ... Soudeh Ghafouri-Fard in Cancer Cell International
    Article Open access 21 July 2022
  2. Cancer Stem Cells (CSCs) in Tumor Ecosystem

    In cancer, cancer stem cells (CSCs) is a unique cell population that could acquire the stemness ability of a stem cell that enable them to...
    Phei Er Saw, Erwei Song in Tumor Ecosystem
    Chapter 2023
  3. Diagnostic and Prognostic Significance of Intracellular Markers of CSCs in Patients with Cancers

    Intracellular markers of cancer stem cells (CSCs), e.g., ALDH1, SOX2, Oct-3/4, Bmi1, LETM1, Msi2, and Sall4 have a significant role in the isolation...
    Kazi Soha, Md. Arifur Rahman, Farhadul Islam in Cancer Stem Cells: Basic Concept and Therapeutic Implications
    Chapter 2023
  4. CD44-Based Detection of CSCs: CD44 Immunodetection by Flow Cytometry

    CD44 has been described in many malignancies as a marker of cancer stem cells (CSCs). Several techniques can be used to detect these cells. Here we...
    Lornella Seeneevassen, Anissa Zaafour, Christine Varon in Cancer Stem Cells
    Protocol 2024
  5. Downregulation of circ-Foxo3 in breast cancer stem-like cells

    Objective

    Cancer cells having stem cell characteristics are linked to metastasis and relapse in breast cancer. Circ-Foxo3, as a circular RNA, has been...

    Mohammad Kamalabadi-Farahani, Amir Atashi, Mohammad Masoud Eslami in BMC Research Notes
    Article Open access 03 July 2023
  6. The transcriptional landscape of cancer stem-like cell functionality in breast cancer

    Background

    Cancer stem-like cells (CSCs) have been extensively researched as the primary drivers of therapy resistance and tumor relapse in patients...

    Oana Baldasici, Olga Soritau, ... Oana Tudoran in Journal of Translational Medicine
    Article Open access 03 June 2024
  7. In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells

    Cancer stem cells (CSCs) play a vital role in metastasis, recurrence and chemoresistance in breast cancer. β-catenin, which is a frequently over...

    Tolulope Peter Saliu, Nirwani Natasha Seneviratne, ... Sameera Ranganath Samarakoon in In Silico Pharmacology
    Article 12 April 2024
  8. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles

    Background

    Cancer stem cells (CSCs) are a subpopulation of cancer cells that are believed to be responsible for tumor initiation, progression,...

    Ozlem Altundag-Erdogan, Rumeysa Tutar, ... Betül Çelebi-Saltik in DARU Journal of Pharmaceutical Sciences
    Article Open access 09 May 2024
  9. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

    TRIM58 is a member of the TRIM protein family, which possess with E3 ubiquitin ligase activities. Studies have revealed that low expression of TRIM58...

    Xujun Li, **g Jiang, ... Fan Yang in Cancer Gene Therapy
    Article 07 May 2024
  10. The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

    Background

    Breast cancer stem cells (BCSCs) are resistant to standard therapies, facilitate tumor dissemination, and contribute to relapse and...

    Deeksha Sharma, Cody G. Hager, ... Monika L. Burness in Breast Cancer Research
    Article Open access 15 November 2023
  11. Targeting Epithelial-to-Mesenchymal Transition for Breast Cancer Stem Cells Therapeutics

    Metastasis of breast cancer cells involves the dissemination from primary tumor sites and migration to distant organs forming secondary tumors, which...
    Shruthi Suthakaran, Digvijay Singh, ... Amitava Das in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  12. Molecular Pathways in Breast Cancer Chemoresistance

    Chemoresistance is one of the determinants of breast cancer (BrCA) prognosis. Chemoresistance leads to recurrence and metastasis that causes adverse...
    Subhayan Das, Moumita Kundu, ... Mahitosh Mandal in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  13. Targeting Epithelial-to-Mesenchymal Transition for Breast Cancer Stem Cells Therapeutics

    Metastasis of breast cancer cells involves the dissemination from primary tumor sites and migration to distant organs forming secondary tumors, which...
    Shruthi Suthakaran, Digvijay Singh, ... Amitava Das in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  14. Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells

    TAB182 participates in DNA damage repair and radio-/chemosensitivity regulation in various tumors, but its role in tumorigenesis and therapeutic...

    Huan He, Shaozheng Wang, ... **kun Zhou in BMC Cancer
    Article Open access 13 November 2023
  15. Resistance to Chemotherapy in Breast Cancer

    Breast cancer (BC) is the most frequently diagnosed cancer in women and the leading cause of death for women worldwide. Conventional clinical...
    Richard Khanyile, Thabiso Victor Miya, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  16. Cuproptosis engages in c-Myc-mediated breast cancer stemness

    Background

    Intra-tumoral heterogeneity (ITH) is a distinguished hallmark of cancer, and cancer stem cells (CSCs) contribute to this malignant...

    Runtian Wang, Kun Xu, ... **aoxiang Guan in Journal of Translational Medicine
    Article Open access 23 June 2023
  17. siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression

    Background

    Breast cancer, the most prevalent cancer in women worldwide, faces treatment challenges due to drug resistance, posing a serious threat to...

    Prakash Chaudhary, Kiran Yadav, ... Jung-Ae Kim in Breast Cancer Research
    Article Open access 25 April 2024
  18. Harnessing the Power of Natural Products in Overcoming Drug Resistance in Breast Cancer

    This chapter explores the use of substances, including cannabis, curcumin, resveratrol, and green tea polyphenols, in the fight against drug...
    Nkhensani Y. Chauke-Malinga, Alaouna Mohammed, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  19. Nanomedicine Targeting Cancer Stem Cells

    Cancer stem cells (CSCs) constitute a subset of cells endowed with the remarkable abilities of self-renewal, proliferation, and differentiation....
    Ankita Dhangar, Tabassum Khan, Abdelwahab Omri in Personalized and Precision Nanomedicine for Cancer Treatment
    Chapter 2024
  20. Molecular Pathways in Breast Cancer Chemoresistance

    Chemoresistance is one of the determinants of breast cancer (BrCA) prognosis. Chemoresistance leads to recurrence and metastasis that causes adverse...
    Subhayan Das, Moumita Kundu, ... Mahitosh Mandal in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
Did you find what you were looking for? Share feedback.